BioCardia (BCDA) Assets Average (2011 - 2026)

BioCardia (BCDA) has reported Assets Average for 14 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 51.99% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 51.99% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 6.35% from the prior year.
• Assets Average was $3.2 million for Q2 2026 at BioCardia, up from $2.6 million in the prior quarter.
• Over five years, Assets Average peaked at $14.3 million in Q1 2022 and troughed at $2.1 million in Q2 2025.
• A 5-year average of $5.8 million and a median of $4.7 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average sank 66.51% in 2024 and soared 51.99% in 2026, its largest moves.
• Over 5 years, Assets Average stood at $9.5 million in 2022, then sank by 64.51% to $3.4 million in 2023, then soared by 48.37% to $5.0 million in 2024, then decreased by 4.3% to $4.8 million in 2025, then plunged by 32.36% to $3.2 million in 2026.
• The last three Assets Average figures came in at $3.2 million (Q2 2026), $2.6 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.